Growth Bets Drive Market Pulse Ahead of Earnings

September 25, 2025

DENVER, Colo., Sep 25, 2025 (247marketnews.com)- VENU (NYSE:VENU) is fueled by a Younger Associates report projecting $17.6 billion in economic impact and 4,700 jobs over 20 years from venues like Sunset McKinney ($5.9B, 1,463 jobs) and El Paso ($5.4B, 2,100 jobs). Every project transforms “not just local economies, but entire regions,” said CEO J.W. Roth. With a $5 billion pipeline targeting 40 venues by 2030, VENU’s Ford Amphitheater hosted 100,000+ fans in 2024, earning a 2024 Pollstar nod.

Evaxion Biotech (NASDAQ:EVAX) is soaring after out-licensing EVX-B3 to MSD/Merck (NYSE:MRK) for $7.5 million, extending cash runway to H1 2027. “This has significant financial value for us, but equally important is the massive validation of our AI-Immunology platform by MSD,” said CSO Birgitte Rønø, with up to $592 million in milestones possible. MSD’s EVX-B2 option (gonorrhea vaccine) extends to H1 2026, eyeing another $592 million in a $200 billion vaccine market. A 2:30 p.m. CT webcast today details next steps.

Tesla (NASDAQ:TSLA) is revving for a seventh-month rally, after Piper Sandler hiked its target to $500 from $400, on Tuesday, keeping Overweight on “unmatched AI and autonomy progress.” With 45% YTD gains and $1.8 trillion market cap, TSLA eyes Q3 deliveries (October 2), projecting 460,000 units despite tariff headwinds in a $1.2 trillion EV market (15% CAGR).

Accenture (NYSE:ACN) is reporting Q4 earnings today, expected at $2.75 EPS on $17.2 billion revenue (consensus). Q3’s 3% YoY growth to $16.5 billion and “accelerated AI bookings” per CEO Julie Sweet fuel optimism in a $500 billion IT services sector. Buybacks ($4 billion YTD) and a 1.5% dividend yield support stability.

Costco (NASDAQ:COST) is reporting earnings after today’s close, with consensus eyeing $5.08 EPS on $82 billion Q4 sales. August’s 7% same-store growth and 92% membership renewal rate signal strength in a $1.5 trillion retail market. “Our focus on value drives loyalty,” management noted, with analysts projecting 8% upside to $1,000.

PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (XHLD, EVAX, TSLA, MRK, COST, ACN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.